Known targets — ChEMBL curated mechanism
AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA
The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CES2 | O00748 | 4/20 | 0.40 |
| ▸ | CES1 | P23141 | 4/20 | 0.40 |
| ▸ | FABP3 | P05413 | 3/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1225942 | 0.96 | CA1 (0.50) | CA1CA2CES2CES1EPHX1 | |
| SCHEMBL1249777 | 0.96 | CA1 (0.50) | CA1CA2CES2CES1EPHX1 | |
| Potassium Ion SCHEMBL29216578 | 0.83 | CA1 (0.46) | CA1CA2CES2CES1FABP3 | |
| SCHEMBL740194 | 0.80 | ACE2 (0.46) | FABP3GPR84 | |
| SCHEMBL163902 | 0.80 | ACE2 (0.46) | FABP3GPR84 | |
| SCHEMBL3277793 | 0.79 | CA1 (0.48) | CA1CA2CES2CES1GPR84 | |
| SCHEMBL6673311 | 0.78 | ACE2 (0.44) | FABP3GPR84 | |
| SCHEMBL3260570 | 0.77 | CA1 (0.50) | CA1CA2CES2CES1GPR84 | |
| SCHEMBL861850 | 0.77 | CA1 (0.50) | CA1CA2CES2CES1GPR84 | |
| Phosphoric Acid SCHEMBL4688075 | 0.74 | GGPS1 (0.41) | GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260076367-A1 | ENDOSCOPE DISINFECTANT | WHITELEY CORP PTY LTD (AU) | 2026-03-19 | — | — | US | claimed |
| US-12427215-B2 | Endoscope disinfectant | WHITELEY CORPORATION PTY LTD (AU) | 2025-09-30 | — | — | US | claimed |
| CN-118140923-A | Improved Endoscope Disinfectant | 怀特利集团控股有限公司 | 2024-06-07 | — | — | CN | claimed |
| CN-113645845-B | Improved endoscope disinfectant | 怀特利集团控股有限公司 | 2024-04-19 | — | — | CN | claimed |
| US-20220023475-A1 | IMPROVED ENDOSCOPE DISINFECTANT | WHITELEY CORPORATION PTY LTD (AU) | 2022-01-27 | — | — | US | claimed |
| EP-3923721-A1 | IMPROVED ENDOSCOPE DISINFECTANT | Whiteley Corporation Pty Ltd (AU) | 2021-12-22 | — | — | EP | claimed |
| CN-113645845-A | Improved endoscope disinfectant | 怀特利集团控股有限公司 | 2021-11-12 | — | — | CN | claimed |
| WO-2020163900-A1 | IMPROVED ENDOSCOPE DISINFECTANT | WHITELEY CORPORATION PTY LTD (AU) | 2020-08-20 | — | — | WO | claimed |
| US-20260076367-A1 | ENDOSCOPE DISINFECTANT | WHITELEY CORP PTY LTD (AU) | 2026-03-19 | — | — | US | disclosed |
| US-12427215-B2 | Endoscope disinfectant | WHITELEY CORPORATION PTY LTD (AU) | 2025-09-30 | — | — | US | disclosed |
| CN-118140923-A | Improved Endoscope Disinfectant | 怀特利集团控股有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-113645845-B | Improved endoscope disinfectant | 怀特利集团控股有限公司 | 2024-04-19 | — | — | CN | disclosed |
| US-20220023475-A1 | IMPROVED ENDOSCOPE DISINFECTANT | WHITELEY CORPORATION PTY LTD (AU) | 2022-01-27 | — | — | US | disclosed |
| EP-3923721-A1 | IMPROVED ENDOSCOPE DISINFECTANT | Whiteley Corporation Pty Ltd (AU) | 2021-12-22 | — | — | EP | disclosed |
| CN-113645845-A | Improved endoscope disinfectant | 怀特利集团控股有限公司 | 2021-11-12 | — | — | CN | disclosed |
| WO-2020163900-A1 | IMPROVED ENDOSCOPE DISINFECTANT | WHITELEY CORPORATION PTY LTD (AU) | 2020-08-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260076367-A1 | ENDOSCOPE DISINFECTANT | PMS2, GABBR1, GABRP | CA1 673/4885CA2 692/4885CES2 3193/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.